|
The Breast Cancer Risk Assessment
Tool was developed by scientists at the National Cancer Institute and the
National Surgical Adjuvant Breast and Bowel Project (NSABP) to assist health
care providers in discussing breast cancer risk and tamoxifen with their female
patients. The tool allows one to project a woman's individual estimate of breast
cancer risk over a 5-year period of time and over her lifetime. It also compares
the woman's risk calculation with the average risk for a woman of the same age.
Information about the risks and benefits of taking tamoxifen are included. This
version of the risk tool enables a health care provider to print the results
of a woman's risk calculation directly from the Internet.
NCI's Cancer.Gov Breast
Cancer page
View/Order
NCI Print Materials on Breast Cancer
Web Tutorial
on Estrogen Receptors, Tamoxifen, and Raloxifene
STAR (Study of Tamoxifen and Raloxifene)
Trial Information:
Postmenopausal women in the United
States and Puerto Rico who are interested in participating in STAR can call
the NCI's Cancer Information Service
at 1-800-4-CANCER (1-800-422-6237) for information in English or Spanish. The
number for callers with TTY equipment is 1-800-332-8615.
If you have any suggestions or comments that you wish to share with staff at
the National Cancer Institute's Office of Communications, please e-mail them
to sreditor@mail.nih.gov.
 Back to Top |
